88
Participants
Start Date
July 31, 2013
Primary Completion Date
March 31, 2016
Study Completion Date
February 22, 2017
teprotumumab
normal saline
Fondazione Ca' Granda Ospedale Policlinico Graves GO Center, Milan
Emory University Department of Ophthalmology, Atlanta
Hamilton Eye Institute at University of Tennessee, Memphis
Kellogg Eye Center at University of Michigan, Ann Arbor
University of Iowa Hospitals and Clinics, Department of Ophthalmology, Iowa City
Medical College of Wisconsin, The Eye Institute, Milwaukee
Johannes Gutenberg University Medical Center, Mainz
University of Pisa, Azienda Ospedaliera, Pisa
Washington University Department of Ophthalmology, St Louis
University of Nebraska Medical Center Department of Ophthalmology, Omaha
Eye Wellness Center, Houston
University of Denver, Aurora
Jules Stein Eye Institute at UCLA, Los Angeles
Casey Eye Institute at Oregon Health and Science University, Portland
Moorfields Eye Hospital, London
Lead Sponsor
Amgen
INDUSTRY